SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-213192
Filing Date
2011-08-08
Accepted
2011-08-08 06:07:26
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 669348
2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex311.htm EX-31.1 10656
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex312.htm EX-31.2 10388
4 CERTIFICATIONS PURSUANT TO U.S.C. SECTION 1350 dex321.htm EX-32.1 4295
  Complete submission text file 0001193125-11-213192.txt   5309675

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amln-20110630.xml EX-101.INS 912068
6 XBRL TAXONOMY EXTENSION SCHEMA amln-20110630.xsd EX-101.SCH 53281
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amln-20110630_cal.xml EX-101.CAL 51524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amln-20110630_def.xml EX-101.DEF 125657
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amln-20110630_lab.xml EX-101.LAB 337243
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amln-20110630_pre.xml EX-101.PRE 262874
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 111015574
SIC: 2834 Pharmaceutical Preparations